Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion type Assertion NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_head.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion description "[Our data demonstrate that NPC1L1 2/2 haplotype was associated with variation in LDL-apoB metabolism and its response to statin therapy in centrally obese men, by a mechanism that did not involve changes in VLDL-apoB kinetics, nor cholesterol synthesis or absorption.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_provenance.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion evidence source_evidence_literature NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_provenance.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion SIO_000772 18031309 NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_provenance.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion wasDerivedFrom befree-20140225 NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_provenance.
- NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_assertion wasGeneratedBy ECO_0000203 NP336197.RAA6mSoADmhOOVSdDt_juki9z7aAf31fUklYH_vZVYPV0130_provenance.